GF
BIIB icon

Gerstein Fisher’s Biogen BIIB Stock Holding History

Gerstein Fisher’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$275K Sell
879
-78
-8% -$23.1K 0.03% 345
2016
Q2 		$231K Buy
957
+97
+11% +$25.6K 0.03% 355
2016
Q1 		$224K Sell
860
-81
-9% -$21.4K 0.03% 354
2015
Q4 		$288K Sell
941
-1,960
-68% -$563K 0.04% 314
2015
Q3 		$847K Sell
2,901
-11
-0.4% -$3.63K 0.13% 151
2015
Q2 		$1.18M Buy
2,912
+67
+2% +$26.9K 0.19% 122
2015
Q1 		$1.2M Sell
2,845
-91
-3% -$35.9K 0.2% 114
2014
Q4 		$1M Sell
2,936
-88
-3% -$28.5K 0.16% 128
2014
Q3 		$1M Buy
3,024
+1,368
+83% +$451K 0.18% 116
2014
Q2 		$522K Buy
1,656
+13
+0.8% +$3.91K 0.1% 169
2014
Q1 		$503K Sell
1,643
-8,393
-84% -$2.66M 0.1% 170
2013
Q4 		$13.5M Buy
10,036
+3,387
+51% +$876K 0.5% 52
2013
Q3 		$1.6M Buy
6,649
+2,830
+74% +$633K 0.35% 51
2013
Q2 		$822K Buy
+3,819
New +$816K 0.2% 101

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gerstein Fisher's BIIB Position: Q3 2016 in Review

Gerstein Fisher reduced its Biogen (BIIB) stake by 8.2% in Q3 2016, selling an estimated $23.1K and leaving 879 shares worth $275K. The position accounts for 0.03% of the portfolio, ranked #345.

Gerstein Fisher first reported a position in BIIB in Q2 2013 and has held it in 14 quarters since. The position peaked at $13.5M in Q4 2013. 1,013 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Gerstein Fisher held 879 shares of Biogen worth $275K as of Q3 2016.
  • Gerstein Fisher sold 78 Biogen shares in Q3 2016, an estimated $23.1K.
  • Biogen made up 0.03% of Gerstein Fisher's portfolio in Q3 2016, its #345 holding.
  • Gerstein Fisher first reported a position in Biogen in Q2 2013 and has held it in 14 quarters since.
  • Gerstein Fisher's Biogen position peaked at $13.5M in Q4 2013.
  • 1,013 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.